Cargando…

Hypoxia-activated prodrugs and redox-responsive nanocarriers

Hypoxia is one of the marked features of malignant tumors, which is associated with several adaptation changes in the microenvironment of tumor cells. Therefore, targeting tumor hypoxia is a research hotspot for cancer therapy. In this review, we summarize the developing chemotherapeutic drugs for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yun, Ma, Jingwen, Zhan, Yonghua, Xu, Xinyi, Zeng, Qi, Liang, Jimin, Chen, Xueli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202002/
https://www.ncbi.nlm.nih.gov/pubmed/30425475
http://dx.doi.org/10.2147/IJN.S173431